300181 佐力药业
已收盘 10-20 15:00:00
资讯
新帖
简况
股市必读:佐力药业(300181)10月19日董秘有最新回复
证券之星 · 01:19
股市必读:佐力药业(300181)10月19日董秘有最新回复
佐力药业:浙江佐力医药有限公司系公司全资二级子公司
证券之星 · 10-19 16:51
佐力药业:浙江佐力医药有限公司系公司全资二级子公司
佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%
证券之星 · 10-12
佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%
深交所创业板再融资审核动态周报(截止10月10日)
览富财经网 · 10-12
深交所创业板再融资审核动态周报(截止10月10日)
佐力药业:发行可转换公司债券获证监会同意注册批复
每日经济新闻 · 10-11
佐力药业:发行可转换公司债券获证监会同意注册批复
股市必读:佐力药业(300181)9月24日披露最新机构调研信息
证券之星 · 09-28
股市必读:佐力药业(300181)9月24日披露最新机构调研信息
佐力药业:9月23日组织现场参观活动,开源证券参与
证券之星 · 09-24
佐力药业:9月23日组织现场参观活动,开源证券参与
股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》
证券之星 · 09-11
股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》
佐力药业(300181)披露药品生产许可证变更公告,9月1日股价上涨0.81%
证券之星 · 09-01
佐力药业(300181)披露药品生产许可证变更公告,9月1日股价上涨0.81%
开源证券:给予佐力药业买入评级
证券之星 · 09-01
开源证券:给予佐力药业买入评级
佐力药业(300181)6月30日股东户数4.42万户,较上期增加6.37%
证券之星 · 08-28
佐力药业(300181)6月30日股东户数4.42万户,较上期增加6.37%
佐力药业(300181.SZ)发布上半年业绩,归母净利润3.75亿元,同比增长0.38%
智通财经 · 08-27
佐力药业(300181.SZ)发布上半年业绩,归母净利润3.75亿元,同比增长0.38%
图解佐力药业中报:第二季度单季净利润同比下降8.84%
证券之星 · 08-27
图解佐力药业中报:第二季度单季净利润同比下降8.84%
佐力药业2026年半年报:新资产并表助增收,利润增速平缓
蓝鲸财经 · 08-27
佐力药业2026年半年报:新资产并表助增收,利润增速平缓
深交所创业板再融资动态数据周报(2026.08.17-2026.08.23)
中金财经 · 08-25
深交所创业板再融资动态数据周报(2026.08.17-2026.08.23)
佐力药业(300181.SZ):灵莲花颗粒获得药物临床试验批准
智通财经 · 08-12
佐力药业(300181.SZ):灵莲花颗粒获得药物临床试验批准
股市必读:佐力药业新发布《关于2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市的公告》
证券之星 · 08-07
股市必读:佐力药业新发布《关于2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市的公告》
佐力药业(300181)披露2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市公告,8月5日股价下跌1.54%
证券之星 · 08-05
佐力药业(300181)披露2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市公告,8月5日股价下跌1.54%
佐力药业(300181)披露向不特定对象发行可转换公司债券募集说明书(上会稿),7月20日股价上涨6.49%
证券之星 · 07-20
佐力药业(300181)披露向不特定对象发行可转换公司债券募集说明书(上会稿),7月20日股价上涨6.49%
7月20日佐力药业涨6.49%,宏利效率混合LOF基金重仓该股
证券之星 · 07-20
7月20日佐力药业涨6.49%,宏利效率混合LOF基金重仓该股
加载更多
公司概况
公司名称:
浙江佐力药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-02-22
主营业务:
浙江佐力药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是乌灵胶囊、灵泽片、灵莲花颗粒、百令片、百令胶囊、聚卡波非钙片/颗粒。公司荣获“全国文明单位”“国家级绿色工厂”“浙江省知名商号”“浙江省重合同、守信用AAA级企业”“浙江省信用管理示范企业”“浙江省中医药文化宣传教育基地”等称号和荣誉。
发行价格:
23.50
{"stockData":{"symbol":"300181","market":"SZ","secType":"STK","nameCN":"佐力药业","latestPrice":13.18,"timestamp":1792479822000,"preClose":13.27,"halted":0,"volume":6710908,"delay":0,"changeRate":-0.0068,"floatShares":602000000,"shares":701000000,"eps":0.9031,"marketStatus":"已收盘","change":-0.09,"latestTime":"10-20 15:00:00","open":13.26,"high":13.3,"low":13.1,"amount":88467500,"amplitude":0.0151,"askPrice":13.18,"askSize":307,"bidPrice":13.17,"bidSize":514,"shortable":0,"etf":0,"ttmEps":0.9031,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792546200000},"marketStatusCode":5,"adr":0,"adjPreClose":13.27,"symbolType":"stock","openAndCloseTimeList":[[1792459800000,1792467000000],[1792472400000,1792479600000]],"highLimit":14.6,"lowLimit":11.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":701387335,"isCdr":false,"pbRate":2.8,"roa":"--","peRate":14.594176,"roe":"11.25%","epsLYR":0.92,"committee":-0.200253,"marketValue":9244000000,"turnoverRate":0.0111,"status":1,"floatMarketCap":7941000000},"requestUrl":"/m/hq/s/300181","defaultTab":"news","newsList":[{"id":"2676638383","title":"股市必读:佐力药业(300181)10月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2676638383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676638383?lang=zh_cn&edition=full","pubTime":"2026-10-20 01:19","pubTimestamp":1792430348,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘,佐力药业报收于13.27元,上涨1.14%,换手率1.65%,成交量9.92万手,成交额1.32亿元。董秘最新回复投资者: 请问贵公司206年三季报业绩怎么样?公司2026年三季度报告预约披露日为2026年10月28日,具体经营及业绩情况届时请关注公司在法定披露媒体披露的信息。根据公司披露的2026年半年度报告,佐力医药公司商业营业收入较上年同期数增长了49.97%。当日关注点交易信息汇总:10月19日主力资金净流入557.97万元,占总成交额4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000001765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0042","300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676017509","title":"佐力药业:浙江佐力医药有限公司系公司全资二级子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2676017509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676017509?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:51","pubTimestamp":1792399870,"startTime":"0","endTime":"0","summary":"证券之星消息,佐力药业(300181)10月19日在投资者关系平台上答复投资者关心的问题。投资者提问:请问子公司佐力医药在上市公司中的定位,他的业务盈利能力如何?是否存在亏损?佐力药业回复:您好!浙江佐力医药有限公司系公司全资二级子公司,重点经营特色的医药流通业务,作为对主业的协同与补充。根据公司披露的2026年半年度报告,佐力医药公司商业营业收入较上年同期数增长了49.97%。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900021131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1515","300181","09939","BK1574","BK0042","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876964","title":"佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876964?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:52","pubTimestamp":1791798740,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,佐力药业报收于13.31元,较前一交易日上涨0.45%,最新总市值为93.35亿元。近日,浙江佐力药业股份有限公司收到中国证券监督管理委员会出具的《关于同意浙江佐力药业股份有限公司向不特定对象发行可转换公司债券注册的批复》。中国证监会同意公司向不特定对象发行可转换公司债券的注册申请,批复自同意注册之日起12个月内有效。公司董事会将根据相关要求及股东会授权办理后续事宜,并履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300181","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674873406","title":"深交所创业板再融资审核动态周报(截止10月10日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674873406","media":"览富财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674873406?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:04","pubTimestamp":1791795840,"startTime":"0","endTime":"0","summary":"公司2月27日获深交所受理,8月21日经上市审核委员会2026年第52次会议审议通过,保荐机构为国金证券股份有限公司。公司5月15日获深交所受理,9月9日审核通过,9月21日提交注册,保荐机构为国联民生证券承销保荐有限公司。公司于9月23日收到深交所上市审核中心出具的审核中心意见告知函,9月24日公告审核通过,9月30日提交注册。公司6月1日获深交所受理,7月9日已完成首轮问询回复,保荐机构为国泰海通证券股份有限公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-12/doc-iniuyhwz5260372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301251","BK0185","301631","BK0042","BK0214","BK0197","300852","300814","300656","BK0239","300323","BK0091","BK0102","BK0077","BK0170","BK0254","301279","BK0064","300181","BK0141","BK0259","300756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674158812","title":"佐力药业:发行可转换公司债券获证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2674158812","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674158812?lang=zh_cn&edition=full","pubTime":"2026-10-11 16:48","pubTimestamp":1791708480,"startTime":"0","endTime":"0","summary":"每经AI快讯,10月11日,佐力药业公告,公司拟向不特定对象发行可转换公司债券,近日收到中国证监会同意注册批复,批复自同意注册之日起12个月内有效。公司将按相关要求及股东会授权办理本次发行相关事宜。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-11/doc-iniuvxsm8846901.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-11/doc-iniuvxsm8846901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300181","BK0077","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409333","title":"股市必读:佐力药业(300181)9月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409333?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:12","pubTimestamp":1790529132,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,佐力药业报收于12.95元,下跌1.52%,换手率1.28%,成交量7.69万手,成交额1.0亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300181","BK0042","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669305496","title":"佐力药业:9月23日组织现场参观活动,开源证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2669305496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669305496?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:03","pubTimestamp":1790258636,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月24日佐力药业发布公告称公司于2026年9月23日组织现场参观活动,开源证券巢舒然参与。公司中药配方颗粒 2026 年上半年实现营收 9700 多万,同比增长 31%。公司向不特定对象发行可转换公司债券申请已经深交所上市委审核通过,尚需中国证监会同意注册。佐力药业主营业务:药品的研发、生产和销售。该股最近90天内共有3家机构给出评级,买入评级3家。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400040633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","BK0239","161027","300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590395","title":"股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590395?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:41","pubTimestamp":1789062069,"startTime":"0","endTime":"0","summary":"公司公告汇总:佐力药业向不特定对象发行可转债申请已于2026年8月21日获深交所上市审核委员会审议通过,募集说明书等文件已基于2026年半年报完成财务数据更新。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300181","BK0183","600109","BK0042","BK0077","BK0188","BK0201","BK0239","BK0276","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664403852","title":"佐力药业(300181)披露药品生产许可证变更公告,9月1日股价上涨0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664403852","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664403852?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:18","pubTimestamp":1788272336,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,佐力药业报收于13.76元,较前一交易日上涨0.81%,最新总市值为96.51亿元。该股当日开盘13.69元,最高13.77元,最低13.61元,成交额达1.59亿元,换手率为1.93%。近日,浙江佐力药业股份有限公司完成《药品生产许可证》变更,取得浙江省药品监督管理局换发的证书。相关变更已在许可证正本、副本及变更页中载明。此次变更有利于公司拓展产品管线、优化资源配置,短期内对公司业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","BK0239","300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855645","title":"开源证券:给予佐力药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664855645?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:20","pubTimestamp":1788261642,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,巢舒然近期对佐力药业进行研究并发布了研究报告《公司信息更新报告:2026H1业绩稳健增长,构建“乌灵+X”生态体系》,给予佐力药业买入评级。 佐力药业 经营业绩稳健增长,维持“买入”评级 公司2026H1实现营收17.64亿元;归母净利润3.75亿元;扣非归母净利润3.74亿元。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100036460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662291066","title":"佐力药业(300181)6月30日股东户数4.42万户,较上期增加6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662291066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662291066?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:51","pubTimestamp":1787910716,"startTime":"0","endTime":"0","summary":"证券之星消息,近日佐力药业披露,截至2026年6月30日公司股东户数为4.42万户,较3月31日增加2646.0户,增幅为6.37%。在中药行业个股中,佐力药业股东户数低于行业平均水平,截至6月30日,中药行业平均股东户数为5.16万户。从股价来看,2026年3月31日至2026年6月30日,佐力药业区间跌幅为7.51%,在此期间股东户数增加2646.0户,增幅为6.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300181","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662169089","title":"佐力药业(300181.SZ)发布上半年业绩,归母净利润3.75亿元,同比增长0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662169089","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662169089?lang=zh_cn&edition=full","pubTime":"2026-08-27 23:14","pubTimestamp":1787843656,"startTime":"0","endTime":"0","summary":"智通财经APP讯,佐力药业(300181.SZ)发布2026年半年度报告,报告期内,公司实现营业收入17.64亿元,同比增长10.30%。实现归属于上市公司股东的净利润3.75亿元,同比增长0.38%。实现归属于上市公司股东的扣除非经常性损益的净利润3.74亿元,同比增长0.53%。乌灵系列营业收入较上年同期减少了0.82%,百令系列营业收入较上年同期增长了12.87%,中药饮片营业收入较上年同期数减少了13.82%,中药配方颗粒营业收入较上年同期增长了31.29%,多微系列新增营业收入10,047.36万元,佐力医药公司商业营业收入较上年同期数增长了49.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701858","title":"图解佐力药业中报:第二季度单季净利润同比下降8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701858","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662701858?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:11","pubTimestamp":1787829076,"startTime":"0","endTime":"0","summary":"证券之星消息,佐力药业2026年中报显示,上半年度公司主营收入17.64亿元,同比上升10.3%;归母净利润3.75亿元,同比上升0.38%;扣非净利润3.74亿元,同比上升0.53%;其中2026年第二季度,公司单季度主营收入8.66亿元,同比上升11.78%;单季度归母净利润1.75亿元,同比下降8.84%;单季度扣非净利润1.75亿元,同比下降8.16%;负债率34.89%,投资收益-126.16万元,财务费用748.9万元,毛利率62.62%。财报数据概要请见下图:本文数据来源于佐力药业2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703467","title":"佐力药业2026年半年报:新资产并表助增收,利润增速平缓","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703467","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703467?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:38","pubTimestamp":1787823539,"startTime":"0","endTime":"0","summary":"财报数据显示,报告期公司实现营业收入17.64亿元,同比增长10.30%;归母净利润3.75亿元,同比增长0.38%;扣非净利润3.74亿元,同比增长0.53%。经营活动产生的现金流量净额为2.30亿元,同比下降20.53%,主要系职工薪酬及税费支付增加所致。值得注意的是,公司于2025年底收购的多种微量元素注射液资产组在本期贡献营收1.00亿元,毛利率超90%,显著增厚了业绩。医药流通板块营收3.73亿元,同比增长9.24%,但毛利率仅为7.07%,对整体利润贡献有限。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787821408479835594","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0042","300181","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662789590","title":"深交所创业板再融资动态数据周报(2026.08.17-2026.08.23)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662789590","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662789590?lang=zh_cn&edition=full","pubTime":"2026-08-25 14:20","pubTimestamp":1787638801,"startTime":"0","endTime":"0","summary":"览富财经网讯:据深交所官网披露,2026 年 8 月 17 日至 8 月 23 日期间,深交所创业板再融资市场保持活跃,共有 12 家企业的再融资项目迎来关键节点,涵盖受理、问询、审核通过、注册生效及终止等多个环节,合计拟募资金额约 126.34 亿元。受理环节方面,本周共有 4 家企业获受理。问询环节方面,恒勃股份、温州宏丰2 家企业收到问询函。此外,商络电子、泰林生物2 家企业可转债项目终止(撤回),分别拟募资 10 亿元、2.3 亿元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/25/20260825779922.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/25/20260825779922.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260825/32346097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300093","BK0238","300048","BK0235","BK0046","BK0078","BK0146","BK0061","BK0028","BK0239","BK0005","300018","BK0250","301018","300397","BK0024","BK0251","BK0014","301225","BK0264","BK0114","300181","300283","300991","BK0214","BK0102","300975","BK0077","BK0042","BK0039","BK0224","BK0130","301116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658785469","title":"佐力药业(300181.SZ):灵莲花颗粒获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658785469","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658785469?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:51","pubTimestamp":1786524709,"startTime":"0","endTime":"0","summary":"智通财经APP讯,佐力药业 发布公告,公司于近日收到国家药品监督管理局签发的《药物临床试验批准通知书》,同意公司已上市产品灵莲花颗粒开展新增功能主治的临床试验研究。经审查,2026年06月01日受理的灵莲花颗粒临床试验申请符合药品注册的有关要求,在进一步完善临床试验方案的基础上,同意本品开展用于围绝经期综合征伴焦虑状态心肾不交证的临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","PSYK","BMED","300181","BK0042","BK0239","BK0077","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659672","title":"股市必读:佐力药业新发布《关于2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659672","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657659672?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:22","pubTimestamp":1786036934,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘,佐力药业报收于13.99元,下跌0.85%,换手率3.12%,成交量18.84万手,成交额2.63亿元。公司公告汇总:佐力药业完成2024年限制性股票激励计划预留授予部分第一个归属期登记,归属股票30万股,占总股本0.04%,归属价格7.13元/股,公司层面2025年净利润同比增长31.97%。本次归属不设限售期,公司总股本不变,不影响股权结构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300181","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523806","title":"佐力药业(300181)披露2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市公告,8月5日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523806","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657523806?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:20","pubTimestamp":1785939626,"startTime":"0","endTime":"0","summary":"近日,浙江佐力药业股份有限公司发布《关于2024年限制性股票激励计划预留授予部分第一个归属期归属结果暨股份上市的公告》。公告显示,公司于2026年8月5日完成2024年限制性股票激励计划预留授予部分第一个归属期的归属登记,本次归属激励对象共8人,归属股票数量为30万股,占公司总股本的0.04%,股票来源为公司从二级市场回购的A股普通股。本次归属不设限售期,公司总股本不变,不影响股权结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181","BK0077","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652291239","title":"佐力药业(300181)披露向不特定对象发行可转换公司债券募集说明书(上会稿),7月20日股价上涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652291239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652291239?lang=zh_cn&edition=full","pubTime":"2026-07-20 17:43","pubTimestamp":1784540583,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,佐力药业报收于14.77元,较前一交易日上涨6.49%,最新总市值为103.59亿元。该股当日开盘13.82元,最高14.98元,最低13.75元,成交额达6.05亿元,换手率为6.91%。近日,浙江佐力药业股份有限公司发布《向不特定对象发行可转换公司债券募集说明书(上会稿)》。公告显示,本次发行已获董事会及股东大会审议通过。公司主体及债券信用等级均为AA,评级展望稳定。本次发行未提供担保。报告期内财务报告经审计,均出具标准无保留意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000027344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300181","BK0042","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652299880","title":"7月20日佐力药业涨6.49%,宏利效率混合LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652299880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652299880?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:45","pubTimestamp":1784537121,"startTime":"0","endTime":"0","summary":"证券之星消息,7月20日佐力药业涨6.49%,收盘报14.77元,换手率6.91%,成交量41.67万手,成交额6.05亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为宏利基金的宏利效率混合LOF。周笑雯在任的基金产品包括:宏利医药健康混合发起A,管理时间为2023年12月26日至今,期间收益率为-9.06%;宏利效率混合LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000025048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["162207","BK0239","BK0077","BK0042","300181"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792490994566,"stockEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0242},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.1231},{"period":"1year","weight":-0.2514},{"period":"ytd","weight":-0.1361}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0463},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0914},{"period":"1year","weight":-0.0283},{"period":"ytd","weight":-0.0599}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江佐力药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44196人(较上一季度增加6.37%)","perCapita":"13632股","listingDate":"2011-02-22","address":"浙江省湖州市德清县阜溪街道志远北路388号","registeredCapital":"70138万元","survey":" 浙江佐力药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是乌灵胶囊、灵泽片、灵莲花颗粒、百令片、百令胶囊、聚卡波非钙片/颗粒。公司荣获“全国文明单位”“国家级绿色工厂”“浙江省知名商号”“浙江省重合同、守信用AAA级企业”“浙江省信用管理示范企业”“浙江省中医药文化宣传教育基地”等称号和荣誉。","listedPrice":23.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佐力药业,300181,佐力药业股票,佐力药业股票老虎,佐力药业股票老虎国际,佐力药业行情,佐力药业股票行情,佐力药业股价,佐力药业股市,佐力药业股票价格,佐力药业股票交易,佐力药业股票购买,佐力药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}